...past nine years at bluebird bio Inc. (NASDAQ:BLUE), will be stepping down on April 16. Investment firm CBC Group... ...and general counsel at Sarepta Therapeutics Inc. (NASDAQ:SRPT).
Gunjan Ohri
Agilent Technologies Inc.
Turning Point Therapeutics Inc.
Moderna Inc.
CareDx Inc.
CBC Group
Intercept...
...for $300M fund brings in royalty streams for Paratek’s Nuzyra By Paul Bonanos, Associate Editor CBC Group... ...New York, Shanghai, Hong Kong and Beijing.
Paul Bonanos
Nuzyra, omadacycline (ZL-2401, ptk 0796, BAY 73-7388, MK-2764, PTK796)
CBC Group
Paratek...
...and Co. (NYSE:LLY), Blanchard was with Innovent for about 18 months in 2018-19. He joined CBC Group... ...including those in its $310 million series C round in June, also participated in the IPO.CBC Group...
...C-2 equity round, which also included RA Capital, Hillhouse Capital, Decheng Capital, ZJMF, Janus Henderson, CBC Group... ...Lilly and Co. (NYSE:LLY), was CSO at Innovent Biologics Inc. (HKSE:1801) in 2018-19 before joining CBC Group...
...board, succeeds interim CEO Sean Cao. Blanchard was an operating partner at Everest’s founding investor CBC Group... ...as CSO of Innovent Biologics Inc. (HKEX:1801). Cao, who is also a managing director at CBC Group...
...retiring, as CFO. Cooper was finance director at Kennet Partners Ltd. Kerry Blanchard has joined CBC Group... ...Inc.
Verseau Therapeutics Inc.
Flagship Pioneering
Inozyme Pharma Inc.
Theragnostics Ltd.
Prescient Medicine Holdings Inc.
Orion Biotechnology Canada Ltd.
Arrowhead Pharmaceuticals Inc.
Abingworth LLP
CBC Group
Diverse...
...past nine years at bluebird bio Inc. (NASDAQ:BLUE), will be stepping down on April 16. Investment firm CBC Group... ...and general counsel at Sarepta Therapeutics Inc. (NASDAQ:SRPT).
Gunjan Ohri
Agilent Technologies Inc.
Turning Point Therapeutics Inc.
Moderna Inc.
CareDx Inc.
CBC Group
Intercept...
...for $300M fund brings in royalty streams for Paratek’s Nuzyra By Paul Bonanos, Associate Editor CBC Group... ...New York, Shanghai, Hong Kong and Beijing.
Paul Bonanos
Nuzyra, omadacycline (ZL-2401, ptk 0796, BAY 73-7388, MK-2764, PTK796)
CBC Group
Paratek...
...and Co. (NYSE:LLY), Blanchard was with Innovent for about 18 months in 2018-19. He joined CBC Group... ...including those in its $310 million series C round in June, also participated in the IPO.CBC Group...
...C-2 equity round, which also included RA Capital, Hillhouse Capital, Decheng Capital, ZJMF, Janus Henderson, CBC Group... ...Lilly and Co. (NYSE:LLY), was CSO at Innovent Biologics Inc. (HKSE:1801) in 2018-19 before joining CBC Group...
...board, succeeds interim CEO Sean Cao. Blanchard was an operating partner at Everest’s founding investor CBC Group... ...as CSO of Innovent Biologics Inc. (HKEX:1801). Cao, who is also a managing director at CBC Group...
...retiring, as CFO. Cooper was finance director at Kennet Partners Ltd. Kerry Blanchard has joined CBC Group... ...Inc.
Verseau Therapeutics Inc.
Flagship Pioneering
Inozyme Pharma Inc.
Theragnostics Ltd.
Prescient Medicine Holdings Inc.
Orion Biotechnology Canada Ltd.
Arrowhead Pharmaceuticals Inc.
Abingworth LLP
CBC Group
Diverse...